Akira Shimizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akira Shimizu has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
Osamu Ishikawa
Department of Dermatology Gunma University Graduate School of Medicine Maebashi Japan
18 shared publicationsKazushi Anzawa
Department of Dermatology Kanazawa Medical University Kahoku‐gun Ishikawa Japan
17 shared publications- Osamu Ishikawa
Department of Dermatology Gunma University Graduate School of Medicine Maebashi Japan
15 shared publications - Sei‐Ichiro Motegi
Department of Dermatology Gunma University Graduate School of Medicine Maebashi Japan
12 shared publications Hiroto Ono
Department of Dermatology, Kanazawa Medical University
10 shared publications- Yuko Kuriyama
Department of Dermatology Gunma University Graduate School of Medicine Maebashi Japan
10 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Wiley in The Journal of Dermatology
Investigation of the Efficacy and Safety of TO ‐208 in Patients 2 Years of Age or Older With Molluscum Contagiosum in Japan: A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Study (208‐3‐1) and Its Open‐Label Extension
Molluscum contagiosum (MC) is a common viral skin infection in children. In the two Phase 3 Cantharidin Application in Molluscum Patients [CAMP‐1 and CAMP‐2] studies, cantharidin, a drug‐device combination containing cantharidin (0.7%), a topical vesicant, was significantly superior to placebo in achieving complete clearance of MC lesions at the end of the study. The aim of this study was to evaluate the efficacy and safety of TO‐208, a drug‐device combination containing 0.7% w/v cantharidin, compared with a placebo in patients with MC in Japan. In this Phase 3, double‐blind study, patients aged ≥ 2 years with ≥ 5 MC lesions at baseline were randomly assigned (1:1 ratio) to the TO‐208 group or placebo group, with up to 4 applications every 21 days. The primary efficacy endpoint was the proportion of subjects with complete MC lesion clearance (baseline and new) at Day 85. The full analysis set was conducted for the efficacy population. The secondary efficacy outcome was the percentage change from baseline in the total number of MC lesions, including both baseline and newly developed lesions. The safety endpoints were adverse events and local skin reactions. In total, 148 subjects received TO‐208 and 155 received placebo. The proportion of subjects achieving complete clearance at Day 85 was significantly higher with TO‐208 compared to placebo 50.0% versus 23.2% ( p < 0.001). The percentage change in MC lesions from baseline to Day 85 was −88.35% versus −44.57% ( p < 0.001). Commonly reported adverse events with TO‐208 were mild or moderate blistering, pruritus, pain, and erythema at the application site. Overall, TO‐208 was significantly superior to the placebo in achieving complete clearance of MC lesions at the end of the study visit and was generally well tolerated, with adverse events that were predominantly mild to moderate in severity and limited to application sites. Trial Registration: Japan Registry of Clinical Trials: jRCT2041220039
- 28 September 2026
- Published by Wiley in The Journal of Dermatology
Open AccessInvestigation of the Efficacy and Safety of TO ‐208 in Patients 2 Years of Age or Older With Molluscum Contagiosum in Japan: A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Study (208‐3‐1) and Its Open‐Label Extension
Molluscum contagiosum (MC) is a common viral skin infection in children. In the two Phase 3 Cantharidin Application in Molluscum Patients [CAMP‐1 and CAMP‐2] studies, cantharidin, a drug‐device combination containing cantharidin (0.7%), a topical vesicant, was significantly superior to placebo in achieving complete clearance of MC lesions at the end of the study. The aim of this study was to evaluate the efficacy and safety of TO‐208, a drug‐device combination containing 0.7% w/v cantharidin, compared with a placebo in patients with MC in Japan. In this Phase 3, double‐blind study, patients aged ≥ 2 years with ≥ 5 MC lesions at baseline were randomly assigned (1:1 ratio) to the TO‐208 group or placebo group, with up to 4 applications every 21 days. The primary efficacy endpoint was the proportion of subjects with complete MC lesion clearance (baseline and new) at Day 85. The full analysis set was conducted for the efficacy population. The secondary efficacy outcome was the percentage change from baseline in the total number of MC lesions, including both baseline and newly developed lesions. The safety endpoints were adverse events and local skin reactions. In total, 148 subjects received TO‐208 and 155 received placebo. The proportion of subjects achieving complete clearance at Day 85 was significantly higher with TO‐208 compared to placebo 50.0% versus 23.2% ( p < 0.001). The percentage change in MC lesions from baseline to Day 85 was −88.35% versus −44.57% ( p < 0.001). Commonly reported adverse events with TO‐208 were mild or moderate blistering, pruritus, pain, and erythema at the application site. Overall, TO‐208 was significantly superior to the placebo in achieving complete clearance of MC lesions at the end of the study visit and was generally well tolerated, with adverse events that were predominantly mild to moderate in severity and limited to application sites. Trial Registration: Japan Registry of Clinical Trials: jRCT2041220039
- Open Access
- 23 September 2026
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 9, 17427
Case Report: Sjögren’s disease diagnosed following generalized anhidrosis
Sjögren’s disease typically presents with initial symptoms such as dry mouth, dry eyes, fatigue, and joint pain. This report describes a case of Sjögren’s disease diagnosed following the onset of generalized anhidrosis. The patient had experienced anhidrosis and elevated body temperature for the past 10 yrs. Physical examination revealed no skin rash or cholinergic urticaria. The Minor’s test revealed anhidrosis over 98% of the body surface area. Although idiopathic anhidrosis was initially suspected, a detailed medical history revealed a history of dry eyes, dry mouth, and extensive dental caries. Laboratory tests showed positive antinuclear antibodies and anti-SS-A/Ro antibodies, while serum carcinoembryonic antigen levels and thyroid function were normal. Salivary gland scintigraphy and biopsy confirmed the diagnosis of Sjögren’s disease. Histopathological examination of the anhidrotic areas revealed no obvious inflammatory cell infiltration or glandular atrophy characteristic of Sjögren’s disease, but showed hydropic degeneration of the sweat glands and disruption of the two-cell-layer structure of clear and dark cells. These characteristic pathological changes are observed in acquired idiopathic generalized anhidrosis. However, this patient was a woman in her 50s who lacked typical features of acquired idiopathic generalized anhidrosis, such as elevated serum carcinoembryonic antigen levels and cholinergic urticaria. She did not respond to a half-pulse steroid therapy. Taking these factors into account, it was determined that this case was clinically diagnosed generalized anhidrosis associated with Sjögren’s disease. This case represents a valuable example of a diagnosis of Sjögren’s disease arising from the atypical initial symptom of generalized anhidrosis. In patients with anhidrosis, particularly those suspected of having acquired idiopathic generalized anhidrosis, it is extremely important to conduct a detailed medical history and systematic evaluation to ensure that underlying autoimmune diseases are not overlooked.
- 23 September 2026
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 9, 17427
Open AccessCase Report: Sjögren’s disease diagnosed following generalized anhidrosis
Sjögren’s disease typically presents with initial symptoms such as dry mouth, dry eyes, fatigue, and joint pain. This report describes a case of Sjögren’s disease diagnosed following the onset of generalized anhidrosis. The patient had experienced anhidrosis and elevated body temperature for the past 10 yrs. Physical examination revealed no skin rash or cholinergic urticaria. The Minor’s test revealed anhidrosis over 98% of the body surface area. Although idiopathic anhidrosis was initially suspected, a detailed medical history revealed a history of dry eyes, dry mouth, and extensive dental caries. Laboratory tests showed positive antinuclear antibodies and anti-SS-A/Ro antibodies, while serum carcinoembryonic antigen levels and thyroid function were normal. Salivary gland scintigraphy and biopsy confirmed the diagnosis of Sjögren’s disease. Histopathological examination of the anhidrotic areas revealed no obvious inflammatory cell infiltration or glandular atrophy characteristic of Sjögren’s disease, but showed hydropic degeneration of the sweat glands and disruption of the two-cell-layer structure of clear and dark cells. These characteristic pathological changes are observed in acquired idiopathic generalized anhidrosis. However, this patient was a woman in her 50s who lacked typical features of acquired idiopathic generalized anhidrosis, such as elevated serum carcinoembryonic antigen levels and cholinergic urticaria. She did not respond to a half-pulse steroid therapy. Taking these factors into account, it was determined that this case was clinically diagnosed generalized anhidrosis associated with Sjögren’s disease. This case represents a valuable example of a diagnosis of Sjögren’s disease arising from the atypical initial symptom of generalized anhidrosis. In patients with anhidrosis, particularly those suspected of having acquired idiopathic generalized anhidrosis, it is extremely important to conduct a detailed medical history and systematic evaluation to ensure that underlying autoimmune diseases are not overlooked.
- 21 September 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11)
Tinea Incognito Caused by Trichophyton mentagrophytes With Spongiform Pustule: A Histopathological Pitfall Mimicking Pustular Psoriasis
- 21 September 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11)
Tinea Incognito Caused by Trichophyton mentagrophytes With Spongiform Pustule: A Histopathological Pitfall Mimicking Pustular Psoriasis
- 9 July 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (9) , 1388-1391
HPV29 ‐Associated Periungual Epidermoid/Verrucous Cyst
More than 230 human papillomavirus (HPV) types have been identified, and HPV infection has been implicated in the development of epidermoid cysts arising in hairless skin, such as the palms and soles. HPV‐associated epidermoid cysts are defined by the presence of HPV DNA within the cyst epithelium, with HPV60 being the most frequently detected type. We report a rare case of an HPV29‐associated periungual epidermoid/verrucous cyst with verrucous features in a healthy woman in her seventies. She presented with a painful keratotic lesion around the right third fingernail that had persisted for 2 years and was refractory to cryotherapy. Histopathological examination revealed a cystic structure lined by stratified squamous epithelium containing keratinized material, together with distinctive cytopathic changes in the cyst wall. DNA extracted from formalin‐fixed paraffin‐embedded tissue identified HPV29 by polymerase chain reaction and direct sequencing. RNA in situ hybridization demonstrated HPV29 E6/E7 mRNA signals throughout all layers of the cyst epithelium, indicating transcriptionally active infection. HPV29 is an alpha‐papillomavirus that has only rarely been detected in cutaneous lesions. To our knowledge, this is the first report of an epidermoid/verrucous cyst caused by HPV29 and the first demonstration of transcriptionally active HPV29 infection by RNA in situ hybridization.
- 9 July 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (9) , 1388-1391
HPV29 ‐Associated Periungual Epidermoid/Verrucous Cyst
More than 230 human papillomavirus (HPV) types have been identified, and HPV infection has been implicated in the development of epidermoid cysts arising in hairless skin, such as the palms and soles. HPV‐associated epidermoid cysts are defined by the presence of HPV DNA within the cyst epithelium, with HPV60 being the most frequently detected type. We report a rare case of an HPV29‐associated periungual epidermoid/verrucous cyst with verrucous features in a healthy woman in her seventies. She presented with a painful keratotic lesion around the right third fingernail that had persisted for 2 years and was refractory to cryotherapy. Histopathological examination revealed a cystic structure lined by stratified squamous epithelium containing keratinized material, together with distinctive cytopathic changes in the cyst wall. DNA extracted from formalin‐fixed paraffin‐embedded tissue identified HPV29 by polymerase chain reaction and direct sequencing. RNA in situ hybridization demonstrated HPV29 E6/E7 mRNA signals throughout all layers of the cyst epithelium, indicating transcriptionally active infection. HPV29 is an alpha‐papillomavirus that has only rarely been detected in cutaneous lesions. To our knowledge, this is the first report of an epidermoid/verrucous cyst caused by HPV29 and the first demonstration of transcriptionally active HPV29 infection by RNA in situ hybridization.
- Open Access
- 20 March 2026
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 9, 16180
Case Report: A case with Xeroderma pigmentosum type F manifested a mild phenotype due to a deep intronic variant of the ERCC4 gene
Xeroderma pigmentosum (XP) is a disorder that causes sun sensitivity, pigmented spots in sun-exposed areas, and neurological symptoms due to an inborn error in the DNA repair process for damage caused by sun exposure. We report a case with XP type F (XPF) diagnosed in a patient in her 70s. We identified that she was homozygous for a deep intronic variant of ERCC4 , NC_000016.10(NM_005236.3): c.207+196T>A. This variant causes aberrant mRNA splicing, which confirmed the diagnosis of XP. Seven cases with the same intronic variant have been reported in Japan. In our case, we independently analyzed the qualitative and quantitative aspects of abnormal mRNA splicing, which had not been reported previously, and found approximately 7.7% of the mRNA retained normal splicing. Furthermore, immunostaining of patient’s skin with anti-ERCC4/XP antibody confirmed that the ERCC4 protein was partially expressed rather than being completely absent. This partial expression was predicted to be associated with the relatively mild phenotype observed in our patient.
- 20 March 2026
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 9, 16180
Open AccessCase Report: A case with Xeroderma pigmentosum type F manifested a mild phenotype due to a deep intronic variant of the ERCC4 gene
Xeroderma pigmentosum (XP) is a disorder that causes sun sensitivity, pigmented spots in sun-exposed areas, and neurological symptoms due to an inborn error in the DNA repair process for damage caused by sun exposure. We report a case with XP type F (XPF) diagnosed in a patient in her 70s. We identified that she was homozygous for a deep intronic variant of ERCC4 , NC_000016.10(NM_005236.3): c.207+196T>A. This variant causes aberrant mRNA splicing, which confirmed the diagnosis of XP. Seven cases with the same intronic variant have been reported in Japan. In our case, we independently analyzed the qualitative and quantitative aspects of abnormal mRNA splicing, which had not been reported previously, and found approximately 7.7% of the mRNA retained normal splicing. Furthermore, immunostaining of patient’s skin with anti-ERCC4/XP antibody confirmed that the ERCC4 protein was partially expressed rather than being completely absent. This partial expression was predicted to be associated with the relatively mild phenotype observed in our patient.
- 9 March 2026
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (6) , 506-510
Squamous Cell Carcinoma In Situ Arising From HPV60 ‐Related Plantar Epidermoid Cyst
Palmoplantar epidermoid cysts are typically benign lesions associated with trauma or eccrine duct hypertrophy, occasionally associated with human papillomavirus (HPV) infection, particularly HPV60. Malignant transformation into squamous cell carcinoma (SCC) within these cysts is extremely rare. A 21‐year‐old Japanese woman presented with a slowly enlarging 1.0 cm lesion on her left sole. Ultrasonography suggested a benign cystic lesion, and excisional biopsy was performed. Histopathology revealed an epidermoid cyst with koilocytosis, inclusion bodies, and focal SCC in situ characterized by atypical squamous epithelial proliferation. Immunohistochemical staining showed diffuse p16 positivity, partial Rb loss, and a high Ki67 index in the SCC in situ component. Anti‐HPV antibody (K1H8) was positive in the cyst wall but negative in the SCC in situ. RNAscope analysis demonstrated HPV60‐E6/E7 mRNA expression within the SCC in situ, raising the possibility of HPV‐associated oncogenesis. These findings suggest a potential link between low‐risk HPV60 and cutaneous oncogenesis, emphasizing the need for thorough histopathological evaluation of plantar epidermoid cysts, even in young patients.
- 9 March 2026
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (6) , 506-510
Squamous Cell Carcinoma In Situ Arising From HPV60 ‐Related Plantar Epidermoid Cyst
Palmoplantar epidermoid cysts are typically benign lesions associated with trauma or eccrine duct hypertrophy, occasionally associated with human papillomavirus (HPV) infection, particularly HPV60. Malignant transformation into squamous cell carcinoma (SCC) within these cysts is extremely rare. A 21‐year‐old Japanese woman presented with a slowly enlarging 1.0 cm lesion on her left sole. Ultrasonography suggested a benign cystic lesion, and excisional biopsy was performed. Histopathology revealed an epidermoid cyst with koilocytosis, inclusion bodies, and focal SCC in situ characterized by atypical squamous epithelial proliferation. Immunohistochemical staining showed diffuse p16 positivity, partial Rb loss, and a high Ki67 index in the SCC in situ component. Anti‐HPV antibody (K1H8) was positive in the cyst wall but negative in the SCC in situ. RNAscope analysis demonstrated HPV60‐E6/E7 mRNA expression within the SCC in situ, raising the possibility of HPV‐associated oncogenesis. These findings suggest a potential link between low‐risk HPV60 and cutaneous oncogenesis, emphasizing the need for thorough histopathological evaluation of plantar epidermoid cysts, even in young patients.
- 1 December 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2) , 314-317
A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene
Multifocal venous malformation (VM) is a rare vascular disorder characterized by multiple cutaneous and visceral venous malformations caused by somatic variants in the TEK gene, which encodes the TIE2 receptor. We report a 30‐year‐old man presenting with multiple subcutaneous nodules and oral lesions. MRI revealed multiple masses around the left scapula. A biopsy from a lumbar lesion showed dilated venous channels, and immunohistochemistry was positive for CD31. There was no evidence of anemia. Genetic analysis using next‐generation sequencing of both skin and blood identified two somatic TEK variants, p.(Tyr897Cys) and p.(Arg918His), restricted to the lesion tissue. Bulk phasing analysis revealed that Y897C and R918H existed both as single variants and as double variants in cis. The absence of these variants in blood confirmed their somatic origin. Based on clinical and pathological findings, the patient was diagnosed with multifocal VM. Clinically, this case resembled multifocal sporadic VM; however, the genetic profile was consistent with blue rubber bleb nevus syndrome, suggesting this case may represent an intermediate phenotype between the two entities. The involvement of the PI3K/AKT/mTOR signaling pathway implies potential therapeutic benefit from mTOR inhibitors, such as sirolimus. Close follow‐up is ongoing due to progressive oral involvement.
- 1 December 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2) , 314-317
A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene
Multifocal venous malformation (VM) is a rare vascular disorder characterized by multiple cutaneous and visceral venous malformations caused by somatic variants in the TEK gene, which encodes the TIE2 receptor. We report a 30‐year‐old man presenting with multiple subcutaneous nodules and oral lesions. MRI revealed multiple masses around the left scapula. A biopsy from a lumbar lesion showed dilated venous channels, and immunohistochemistry was positive for CD31. There was no evidence of anemia. Genetic analysis using next‐generation sequencing of both skin and blood identified two somatic TEK variants, p.(Tyr897Cys) and p.(Arg918His), restricted to the lesion tissue. Bulk phasing analysis revealed that Y897C and R918H existed both as single variants and as double variants in cis. The absence of these variants in blood confirmed their somatic origin. Based on clinical and pathological findings, the patient was diagnosed with multifocal VM. Clinically, this case resembled multifocal sporadic VM; however, the genetic profile was consistent with blue rubber bleb nevus syndrome, suggesting this case may represent an intermediate phenotype between the two entities. The involvement of the PI3K/AKT/mTOR signaling pathway implies potential therapeutic benefit from mTOR inhibitors, such as sirolimus. Close follow‐up is ongoing due to progressive oral involvement.
- Open Access
- 1 December 2025
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 8
Case Report: Dermatomyositis with symmetrical axillary and inguinal panniculitis associated with anti-NXP-2
We report a rare case of dermatomyositis in a woman in her 60s, presenting with chronic pruritic erythema and symmetrical subcutaneous indurations in both axillae. Physical examination revealed Gottron’s papules and erythematous plaques on the hands and upper extremities. Laboratory tests showed mildly elevated serum CK, aldolase, and CRP levels. CT revealed increased fat density in both axillae, suggestive of panniculitis. Skin and subcutaneous biopsies confirmed interface dermatitis and panniculitis with membranocystic changes. After that, bilateral inguinal panniculitis developed. Autoantibody screening identified strong positivity for anti-NXP-2 and anti-Ki antibodies. Anti-NXP-2 antibody was further confirmed by immunoprecipitation-Western blotting. The diagnosis of dermatomyositis was made, and oral prednisolone (10 mg, 0.2 mg/kg/day) led to marked improvement. These findings may suggest a potential association between anti-NXP-2 antibodies and panniculitis.
- 1 December 2025
- Published by Frontiers Media SA in Journal of Cutaneous Immunology and Allergy
- Vol. 8
Open AccessCase Report: Dermatomyositis with symmetrical axillary and inguinal panniculitis associated with anti-NXP-2
We report a rare case of dermatomyositis in a woman in her 60s, presenting with chronic pruritic erythema and symmetrical subcutaneous indurations in both axillae. Physical examination revealed Gottron’s papules and erythematous plaques on the hands and upper extremities. Laboratory tests showed mildly elevated serum CK, aldolase, and CRP levels. CT revealed increased fat density in both axillae, suggestive of panniculitis. Skin and subcutaneous biopsies confirmed interface dermatitis and panniculitis with membranocystic changes. After that, bilateral inguinal panniculitis developed. Autoantibody screening identified strong positivity for anti-NXP-2 and anti-Ki antibodies. Anti-NXP-2 antibody was further confirmed by immunoprecipitation-Western blotting. The diagnosis of dermatomyositis was made, and oral prednisolone (10 mg, 0.2 mg/kg/day) led to marked improvement. These findings may suggest a potential association between anti-NXP-2 antibodies and panniculitis.
- 25 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Atypical Deep Dermatophytosis Caused by Trichophyton Rubrum: A Case Report and Literature Review
- 25 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Atypical Deep Dermatophytosis Caused by Trichophyton Rubrum: A Case Report and Literature Review
- 21 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Verrucous Cutaneous Candidiasis on the Dorsum of the Finger
- 21 November 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (2)
Verrucous Cutaneous Candidiasis on the Dorsum of the Finger